Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis

Optimal Anticoagulant Strategy for Periprocedural Management of Atrial Fibrillation Ablation: A Systematic Review and Network Meta-Analysis

This network meta-analysis was performed to rank the safety and efficacy of periprocedural anticoagulant strategies in patients undergoing atrial fibrillation ablation. MEDLINE, EMBASE, CENTRAL, and Web of Science were searched to identify randomized controlled trials comparing anticoagulant regimen...

Full description

Bibliographic Details
Main Authors:	Tabito Kino, Minako Kagimoto, Takayuki Yamada, Satoshi Ishii, Masanari Asai, Shunichi Asano, Hideto Yano, Toshiyuki Ishikawa, Tomoaki Ishigami
Format:	Article
Language:	English
Published:	MDPI AG 2022-03-01
Series:	Journal of Clinical Medicine
Subjects:	periprocedural anticoagulant management atrial fibrillation ablation direct oral anticoagulant vitamin-K antagonist network meta-analysis
Online Access:	https://www.mdpi.com/2077-0383/11/7/1872

Similar Items

Total Thrombus‐Formation Analysis System (T‐TAS) Can Predict Periprocedural Bleeding Events in Patients Undergoing Catheter Ablation for Atrial Fibrillation
by: Miwa Ito, et al.
Published: (2016-01-01)

Clinicians’ adherence to guidelines for the preoperative management of direct oral anticoagulants in a tertiary hospital: a retrospective study
by: Jean Terrier, et al.
Published: (2023-09-01)

Management of dental patients receiving antiplatelet therapy or chronic oral anticoagulation: A review of the latest evidence
by: Csaba András Dézsi, et al.
Published: (2017-10-01)

Fondaparinux Outpatient Use for Patients with a Heparin-Induced Thrombocytopenia History: A Case Report and Review
by: Amy Christopher
Published: (2016-12-01)

Oral anticoagulation – current knowlegde
by: Anna Karaś, et al.
Published: (2022-10-01)

Adaptation of New Oral Anticoagulants for Warfarin Anticoagulated Patient with Traumatic Ongoing Hemorrhage
by: Jin Bong Ye, et al.
Published: (2018-04-01)

Periprocedural Peritonitis Prophylaxis: A Summary of the Microbiology and the Role of Systemic Antimicrobials
by: Leon Hsueh, et al.
Published: (2021-02-01)

Safety and efficacy of treatment with vitamin K antagonists in patients managed in a network of anticoagulation services or as routine general care
by: Gianfranco De Girolamo, et al.
Published: (2022-04-01)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
by: Heng Cai, et al.
Published: (2020-01-01)

The best practices of the Russian Federation in the organization of anticoagulant therapy in patients with high risk of thromboembolic events
by: T. V. Vavilova, et al.
Published: (2020-07-01)

Underutilization of anticoagulants in patients with nonvalvular atrial fibrillation in the era of non-vitamin K antagonist oral anticoagulants
by: Susin Park, et al.
Published: (2022-01-01)

Application of prothrombin complex concentrate for reversal of direct oral anticoagulants in clinical practice: indications, patient characteristics and clinical outcomes compared to reversal of vitamin K antagonists
by: Martin Müller, et al.
Published: (2019-04-01)

Impaired kidney function at ED admission: a comparison of bleeding complications of patients with different oral anticoagulants
by: Martin Müller, et al.
Published: (2021-09-01)

Trends in the Prescription of Non-Vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation: Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Iwona Gorczyca, et al.
Published: (2020-11-01)

Characteristics of Novel Anticoagulants versus Vitamin K Antagonists in the Ventricular Mural Thrombus
by: Qing Yang, et al.
Published: (2023-03-01)

Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study
by: Gilda Denise Zielinski, et al.
Published: (2020-01-01)

Factors Associated with Anticoagulation Adherence in Chinese Patients with Non-Valvular Atrial Fibrillation
by: Song T, et al.
Published: (2021-03-01)

Intracranial hemorrhage in patients taking oral anticoagulants. Current possibilities for therapy
by: S. N. Yanishevsky
Published: (2019-06-01)

Use of Direct Oral Anticoagulants in Patients With Antiphospholipid Syndrome: A Systematic Review and Comparison of the International Guidelines
by: Daniele Pastori, et al.
Published: (2021-08-01)

Activities of daily living predict periprocedural myocardial infarction and injury following percutaneous coronary intervention: a cross-sectional study
by: Yifan Pan, et al.
Published: (2023-08-01)

Periprocedural complications and risk factors after carotid stenting in patients with concomitant coronary artery disease
by: Georgi Goranov, et al.
Published: (2021-12-01)

PRACTICAL CONCERNS OF ANTICOAGULATION IN NONVALVULAR ATRIAL FIBRILLATION: A UNIVERSITY CLINICS REGISTRY
by: A. A. Sokolova, et al.
Published: (2015-09-01)

Periprocedural Direct Oral Anticoagulant Management: The RA-ACOD Prospective, Multicenter Real-World Registry
by: Raquel Ferrandis, et al.
Published: (2020-04-01)

Why Did All Patients with Atrial Fibrillation and High Risk of Stroke Not Receive Oral Anticoagulants? Results of the Polish Atrial Fibrillation (POL-AF) Registry
by: Anna Szpotowicz, et al.
Published: (2021-10-01)

Impact of periprocedural myocardial necrosis on short term clinical outcome
by: Yosef Haggag, et al.
Published: (2017-08-01)

Stroke prevention for non-valvular atrial fibrillation: how to make the right choice of directly acting oral anticoagulants?
by: N. N. Kryukov, et al.
Published: (2019-02-01)

Editorial: Anticoagulation in cardiovascular diseases: evolving role, unmet needs, and grey areas
by: Antonino Tuttolomondo, et al.
Published: (2023-10-01)

Use of idarucizumab in reversing dabigatran anticoagulant effect: a critical appraisal
by: Proietti M, et al.
Published: (2018-08-01)

On-treatment Comparative Effectiveness of Vitamin K Antagonists and Direct Oral Anticoagulants in GARFIELD-VTE, and Focus on Cancer and Renal Disease
by: Sylvia Haas, et al.
Published: (2022-10-01)

Novel oral anticoagulants in primary care in patients with atrial fibrillation: a cross-sectional comparison before and after their introduction
by: Simon Schwill, et al.
Published: (2018-07-01)

Report of periprocedural oral anticoagulants in catheter ablation for atrial fibrillation: The Japanese Catheter Ablation Registry of Atrial Fibrillation (J-CARAF)
by: Yuji Murakawa, MD, et al.
Published: (2017-06-01)

Current approaches to periprocedural anticoagulation treatment in patients undergoing atrial fibrillation ablation
by: N. Z. Gasymova, et al.
Published: (2019-05-01)

Efficacy and safety of novel oral anticoagulants versus vitamin K antagonists in the treatment of venous thromboembolism
by: Maodi Xu, et al.
Published: (2018-09-01)

Better clinical outcome with direct oral anticoagulants in hospitalized heart failure patients with atrial fibrillation
by: Akiomi Yoshihisa, et al.
Published: (2018-01-01)

Beyond warfarin: The advent of new oral anticoagulants
by: Sandeep T Laroia, et al.
Published: (2015-10-01)

Oral Anticoagulants Preference in Hospitalized Patients with Acute Deep Vein Thrombosis or Non-Valvular Atrial Fibrillation
by: Ştefan Cristian Vesa, et al.
Published: (2020-10-01)

Direct oral anticoagulants in atrial fibrillation patients aged 75 years or older: Efficacy and safety balance
by: V V Fomin, et al.
Published: (2017-04-01)

Persistence with Anticoagulation for Atrial Fibrillation: Report from the GLORIA-AF Phase III 1-Year Follow-up
by: Monika Kozieł, et al.
Published: (2020-06-01)

Early Anticoagulation in Patients with Acute Ischemic Stroke Due to Atrial Fibrillation: A Systematic Review and Meta-Analysis
by: Lina Palaiodimou, et al.
Published: (2022-08-01)

Direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension and the presence of recent thrombus during pulmonary endarterectomy
by: Ina Jeong, et al.
Published: (2022-07-01)